Literature DB >> 3009543

Plasma catecholamine modulation of alpha 2 adrenoreceptor agonist affinity and sensitivity in normotensive and hypertensive human platelets.

A S Hollister, J Onrot, S Lonce, J H Nadeau, D Robertson.   

Abstract

We measured alpha 2-adrenoreceptor density as well as affinity for and sensitivity to agonist on intact platelets of normotensive and hypertensive subjects before and after physiological increases in plasma catecholamines. In normotensives, posture-induced rises in plasma catecholamines correlated with reduced alpha 2-adrenoreceptor agonist affinity and fewer high affinity state receptors. Platelet aggregation and inhibition of adenylate cyclase by L-epinephrine also was reduced. Hypertensive subjects had similar rises in plasma catecholamines with upright posture, but showed no change in receptor affinity or sensitivity. No change in platelet alpha 2-adrenoreceptor number occurred in these studies. In vitro incubation with L-epinephrine revealed that platelets from hypertensives had slower desensitization than those from normotensives. Binding studies at different temperatures and with varying sodium concentrations found no thermodynamic or sodium-dependent differences between normotensive and hypertensive groups. These studies demonstrate that platelets from hypertensive subjects exhibit a defect in the ability of physiological concentrations of agonist to desensitize the alpha 2-adrenoreceptor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3009543      PMCID: PMC424540          DOI: 10.1172/JCI112452

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  Reactivity of forearm vessels to vasoconstrictor substances in hypertensive and normotensive subjects.

Authors:  A E DOYLE; J R FRASER; R J MARSHALL
Journal:  Clin Sci       Date:  1959-08       Impact factor: 6.124

2.  Thermodynamics of agonist and antagonist interactions with mammalian beta-adrenergic receptors.

Authors:  G A Weiland; K P Minneman; P B Molinoff
Journal:  Mol Pharmacol       Date:  1980-11       Impact factor: 4.436

3.  Blood pressure response to norepinephrine infusion in relationship to plasma catecholamines and renin activity in man.

Authors:  N D Vlachakis
Journal:  J Clin Pharmacol       Date:  1979-10       Impact factor: 3.126

4.  Pathogenic and therapeutic significance of cardiovascular pressor reactivity as related to plasma catecholamines in borderline and established essential hypertension.

Authors:  P Weidmann; M Grimm; A Meier; Z Glück; G Keusch; I Minder; C Beretta-Piccoli
Journal:  Clin Exp Hypertens       Date:  1980       Impact factor: 1.749

5.  [Hypertensive disease as membrane pathology].

Authors:  I V Postnov
Journal:  Kardiologiia       Date:  1975-08       Impact factor: 0.395

6.  Platelet functions and fatty acid composition of platelet phospholipids in spontaneously hypertensive rats fed saturated or polyunsaturated fats.

Authors:  L McGregor; R Morazain; S Renaud
Journal:  Atherosclerosis       Date:  1981 Jan-Feb       Impact factor: 5.162

7.  Norepinephrine clearance and pressor effect in normal and hypertensive man.

Authors:  M Grimm; P Weidmann; G Keusch; A Meier; Z Glück
Journal:  Klin Wochenschr       Date:  1980-11-03

8.  Differential regulation of the alpha 2-adrenergic receptor by Na+ and guanine nucleotides.

Authors:  T Michel; B B Hoffman; R J Lefkowitz
Journal:  Nature       Date:  1980-12-25       Impact factor: 49.962

9.  Alterations in the responses of the sympathetic nervous system and renin in borderline hypertension.

Authors:  D Robertson; D G Shand; J W Hollifield; A S Nies; J C Frölich; J A Oates
Journal:  Hypertension       Date:  1979 Mar-Apr       Impact factor: 10.190

10.  Platelet aggregation in relationship to plasma catecholamines in patients with hypertension.

Authors:  N D Vlachakis; L Aledort
Journal:  Atherosclerosis       Date:  1979-04       Impact factor: 5.162

View more
  2 in total

1.  Responsiveness of superficial hand veins to phenylephrine in essential hypertension. Alpha adrenergic blockade during prazosin therapy.

Authors:  H G Eichler; G A Ford; T F Blaschke; A Swislocki; B B Hoffman
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

2.  Modulation of vascular function by neuropeptide Y during development of hypertension in spontaneously hypertensive rats.

Authors:  Z Zukowska-Grojec; M Golczynska; G H Shen; A Torres-Duarte; M Haass; C Wahlestedt; A K Myers
Journal:  Pediatr Nephrol       Date:  1993-12       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.